International Workshop on HIV & Women 2023
Related Enduring Materials
Day 1 - Friday, 17 February 2023
Day 2 - Saturday, 18 February 2023
Welcome
The 13th International Workshop on HIV & Women took place in hybrid format from 17-18 February 2023 in Seattle, Washington, United States.
The International Workshop on HIV & Women 2024 will take place in April 2024 in Washington DC, United States.
The International Workshop on HIV & Women has now completed its 13th year and continues to evolve. It is an outstanding opportunity for health care providers, researchers, government, industry, and community representatives to discuss, debate, and further their knowledge on the issues related to HIV and women.
The format of the workshop enables attendees to learn from the world-leading HIV experts, discuss the issues, gaps, and opportunities for further learning and research. Many of the attendees continue to participate each year and have formed valuable relationships and partnerships that have led to collaborative projects.
The enthusiasm and dedication of the participants is palpable throughout the workshop. The debates and round tables are an important vehicle to discuss the issues and challenge dogmas. Over the years, the number and quality of submitted abstracts have continued to improve. The workshop also provides a forum for new investigators to present their work and to personally meet with experts they view as mentors and inspiration for their work. The workshop considers both local and global issues and the information learned in one setting is often translated to another.
We encourage you to consider joining us next year.
On behalf of the Organizing Committee,
Workshop Chair
General Information
- Invited lectures from international experts
- Interactive roundtable sessions
- Ample time for discussion
- Researchers
- OBGYNs
- Government and NGO representatives
- Industry representatives
- Community advocates
- Pharmacists
- Medical Students
- Other healthcare providers involved in daily care of women living with HIV
- Facilitate an unbiased and scientific knowledge exchange regarding HIV, COVID-19 & Women, and encouraging early-career investigators to actively participate in the workshop;
- Summarize and promote the current state of the science regarding HIV, COVID-19 & Women, and its successful translation and dissemination; and
- Foster new and lasting cross-disciplinary partnerships and collaborations between researchers and women, in order to improve knowledge sharing, with the end goal of improving the quality of life of women living with HIV.
- Comprehend the impact of the global crises on access to HIV prevention, treatment, and care for women
- Understand the pros and cons of long-acting formulations for HIV treatment and prevention
- Review guidelines for infant feeding and HIV
- Summarize clinical data on COVID-19 vaccination in women living with HIV
- Outline the impact of emerging infections on women living with HIV
Practical Information
Address:
515 Madison St, Seattle
WA 98104
United States
All registered participants of HIV & Women 2023 can benefit from a 15% discount on the current room rate of the workshop venue.
Further information will be provided upon completion of registration.
Translation will not be provided.
Participants are advised to take out their own insurance policies.
Registration is closed
Please note that payment by credit card is required to be able to register for the workshop. Please contact the conference secretariat if this is not possible for you.
Fees and Conditions
Live Participation
|
Academia |
Industry* |
|
|
Early Fee (payment before/ on 17 July 2022) |
$475.00 |
$1675.00 |
|
Regular Fee (payment before/ on 12 February 2023) |
$955.00 |
$2155.00 |
|
Onsite Fee / Post-Meeting Fee (payment from 13 February 2023) |
$1195.00 |
$2395.00 |
Virtual Participation
|
Academia |
Industry* |
|
|
Early Fee (payment before/ on 17 July 2022) |
$237.50 |
$1675.00 |
|
Regular Fee (payment before/ on 12 February 2023) |
$477.50 |
$2155.00 |
|
Onsite Fee / Post-Meeting Fee (payment from 13 February 2023) |
$597.50 |
$2395.00 |
|
Discounts |
|
|
Early-Career Investigators and/or Academia from Resource-Limited Settings (RLS)** WITH an accepted abstract |
100% Off Early Academia Fee |
|
Early-Career Investigators and/or Academia from Resource-Limited Settings (RLS)** WITHOUT an accepted abstract, NGO Representatives/ Government Representatives (i.e. NIH, NIAID, CDC, etc) / Community Advocates |
50% Off Current Academia Fee |
|
Academia from High-Income Countries*** WITH an accepted abstract |
Early Academia Fee |
|
Representatives of Sponsoring Industry / Endorsing Organizations |
Contact the Secretariat |
*Industry representatives may receive a discount based on the level of support provided to the event. For more support and registration information, please contact us at christina.moustakaki@amededu.com
**Countries included in the low-income and middle-income economies of the World Bank Classification.
***Countries included in the high-income economies of the World Bank Classification.
Important
-
We strongly advise that you register early to ensure your registration. Onsite registration will close when the capacity of the venue is reached.
-
Submission of your online registration does not guarantee that your registration has been accepted. Your registration is final when full prepayment has been received and a confirmation of your registration has been sent.
- Access to all scientific sessions, including poster area
- Workshop pack, including abstract book and program
- Refreshments during the coffee breaks
- Buffet lunch on meeting days
For Virtual Attendees Only:
- Access to all scientific sessions
- Digital workshop pack, including the program book
IMPORTANT:
- No day rate is available
- Payment can only be made by credit card.
- Virology Education reserves the right to cancel improper registrations. Claims for a refund will not be honored.
IMPORTANT: Registration fees waivers are offered to the presenting author only.
To be eligible as an early-career investigator, you should either be a current Master/PhD student or have obtained an MD/PharmD/PhD degree in the last five years. An application form needs to be completed by a supervisor and received by the Virology Education secretariat at least two weeks prior to the start of the workshop. Virology Education will contact the early-career investigator with instructions regarding the registration procedure.
- Cancellation before/on 17 January 2023: 50% refund (minus an administration fee of $40)
- Cancellation after 17 January 2023: Unfortunately, no refund will be given
If you are unable to attend the conference, a substitute delegate is always welcome at no extra charge, provided that a letter of authorization from the original participant has been received and the conference secretariat has been notified of the name of the substitute delegate before 3 February 2023. A statement (email/letter) of cancellation must be sent to Virology Education.
1. Proof of accreditation
2. Valid identification (e.g. passport)
3. A letter from your assignment giver stating the details of your assignment (e.g. editor)
4. At least 3 previous written assignments in recognized outlets on HIV. If you are a freelance journalist, the assignments can be from different (recognizable) news outlets. Links to online publications are accepted
5. The website of the publication(s)/blog(s) that will be featuring your story on this workshop
A partial or full fee waiver may apply for accredited media participants depending on availability. Preference will be given to credible print and online news sources. Please contact the conference secretariat for registration conditions.
We would like to receive a copy of your workshop report/ article once it is finalized.
All credentials will be verified by the Organizing Committee of the Workshop. Media representatives are kindly requested to register by sending the above-mentioned information to info@virology-education.com.
Important: Media is restricted to the written press. Recording on film or photo is not allowed. Virology Education will request a copy of the written piece once it is finalized. Media representatives must also agree to abide by the 2022 embargo policy.
Organizing Committee
HIV & Women 2023 is endorsed by societies and organizations. Their support and collaboration are key to the success of this workshop!
A 25% discount on the academia registration fee is offered to members/employees of endorsers. Please reach out to your organization to obtain the applicable discount code.
If you would like your organization to endorse this workshop, please contact Lara da Silva Miguel at Lara@amededu.com
Support Our Initiative
Financial backing helps us deliver an impactful meeting experience for the benefit of healthcare professionals, researchers, and community representatives involved in the International Workshop on HIV & Women 2023.
This collaboration plays a vital role in both the organizational as well as scientific success of the program.
To show your commitment to the cause and get in touch with us for a tailored support package, please contact Ms. Lara da Silva Miguel at Lara@amededu.com.
Benefits of Support
By supporting this program, we can offer the following advantages for your company.* Please contact us for the most recent support level benefits for this program.
- Symposium opportunities
- Non-commercial interviews with company representatives
- Verbal acknowledgment during the program
- Discounted and complimentary registrations for your representatives
- Company acknowledgment on digital meeting materials including but not limited to newsletters, flyers, the streaming platform, and our website
- Company acknowledgment on printed meeting materials including but not limited to banners and the program book
- Digital and printed advertising opportunities
- Social media shout-outs
- Logo on the conference bag
*Subject to the support level
Risk to Reasons: Reframing Conversations About HIV Risk
This satellite symposium is presented by:
ViiV Healthcare
Women & HIV Symposium: Considerations from Across the Lifespan
This Satellite Symposium is Presented by:
NIH Office of AIDS Research (OAR) and Office of Research on Women’s Health (ORWH)
Group Photo
